Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-1990 | 06-1990 | 03-1990 | 12-1989 | 09-1989 | |
| Sales | 1,057 | 0 | 0 | 2,500 | 0 |
| Gross Profit | 1,057 | 0 | 0 | 2,500 | 0 |
| Operating Expenses | 4,205 | 3,727 | 2,524 | 2,557 | 3,196 |
| Operating Income | -3,148 | -3,727 | -2,524 | -57 | -3,196 |
| Interest Expense | 17 | 19 | 16 | 18 | 12 |
| Other Income | 258 | 3,678 | 126 | -1,766 | 1,107 |
| Pre-tax Income | -2,907 | -68 | -2,415 | -1,841 | -2,101 |
| Net Income Continuous | -2,907 | -68 | -2,415 | -1,841 | -2,101 |
| Net Income | $-2,907 | $-68 | $-2,415 | $-1,841 | $-2,101 |
| EPS Basic Total Ops | -29,072.00 | -681.00 | -24,150.00 | -18,408.00 | -21,007.00 |
| EPS Basic Continuous Ops | -29,072.00 | -681.00 | -24,150.00 | -18,408.00 | -21,007.00 |
| EPS Diluted Total Ops | -29,072.00 | -681.00 | -24,150.00 | -18,408.00 | -21,007.00 |
| EPS Diluted Continuous Ops | -29,072.00 | -681.00 | -24,150.00 | -18,408.00 | -21,007.00 |
| EBITDA(a) | $-3,148 | $-3,727 | $-2,524 | $-57 | $-3,196 |